Q2 2022 Allogene Therapeutics Inc Earnings Call Transcript
Hello. Thank you for standing by, and welcome to Allogene Therapeutics Second Quarter of 2022 Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.
Thank you, operator, and welcome to our Q2 call. After market close, we issued a business update and financial results press release for the second quarter of 2022. This press release and today's webcast are available on our website. We ask you to limit your questions to one per person and we'll do our best to get to as many as possible during the hour.
Joining me today are Dr. David Chang, President and Chief Executive Officer; Dr. Rafael Amado, Executive Vice President of Research and Development; and Dr. Eric Schmidt, Chief Financial Officer.
During today's call, we will be making certain forward-looking statements. These may include statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
